Patents by Inventor Katsuhito Asai

Katsuhito Asai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210030823
    Abstract: According to a conventional method for treatment of Sandhoff disease and Tay-Sachs disease comprising administering a modified ?-subunit to a patient in the form of a protein, it is necessary that administration be performed frequently. This invention relates to a recombinant adeno-associated virus virion comprising: capsomere comprising a protein capable of forming a virus virion; and a polynucleotide packaged in the capsomere comprising a promoter sequence and nucleotide sequences operably linked to the promoter sequence encoding a first amino acid sequence derived from the amino acid sequence of the ?-subunit of wild-type human ?-hexosaminidase composed of amino acids 55 to 556 in the sequence as shown in SEQ ID NO: 28 by substitution of amino acids 312 to 318 with glycine, serine, glutamic acid, proline, serine, glycine, and threonine in that order and a second amino acid sequence, which is an amino acid sequence of a signal peptide linked to the N terminus of the first amino acid.
    Type: Application
    Filed: January 25, 2019
    Publication date: February 4, 2021
    Inventors: Kohji ITOH, Daisuke TSUJI, Shinichi MURAMATSU, Katsuhito ASAI
  • Patent number: 10034911
    Abstract: The present invention provides a novel active ingredient which can be safely used in preventing, ameliorating or treating diseases related to the cartilage such as cartilage damages and cartilage disorders. Since the egg yolk protein hydrolyzate has an effect on chondrocyte proliferation promotion, it is useful as an active ingredient for preventing, ameliorating or treating cartilage disorders and for preventing, ameliorating or treating joint pain. The egg yolk protein hydrolyzate is a natural-origin material with high safety and, therefore, can be widely used in foods and drinks, medicines, feeds and the like which can be daily ingested.
    Type: Grant
    Filed: July 4, 2013
    Date of Patent: July 31, 2018
    Assignee: Pharma Foods International Co., Ltd.
    Inventors: Mujo Kim, Kazuya Watabe, Jiyeong An, Masayoshi Aosasa, Noriko Horie, Kazuyuki Masuda, Katsuhito Asai
  • Publication number: 20150164973
    Abstract: The present invention provides a novel active ingredient which can be safely used in preventing, ameliorating or treating diseases related to the cartilage such as cartilage damages and cartilage disorders. Since the egg yolk protein hydrolyzate has an effect on chondrocyte proliferation promotion, it is useful as an active ingredient for preventing, ameliorating or treating cartilage disorders and for preventing, ameliorating or treating joint pain. The egg yolk protein hydrolyzate is a natural-origin material with high safety and, therefore, can be widely used in foods and drinks, medicines, feeds and the like which can be daily ingested.
    Type: Application
    Filed: July 4, 2013
    Publication date: June 18, 2015
    Inventors: Mujo Kim, Kazuya Watabe, Jiyeong An, Masayoshi Aosasa, Noriko Horie, Kazuyuki Masuda, Katsuhito Asai